These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New lesions after MDT in PB and MB leprosy: a report of 28 cases. Kar HK, Sharma P. Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355 [Abstract] [Full Text] [Related]
6. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I, Dogra S, Kumar B, Radotra BD. Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [Abstract] [Full Text] [Related]
7. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy? Ebenezer GJ, Daniel S, Norman G, Daniel E, Job CK. Indian J Lepr; 2004 Sep; 76(3):199-206. PubMed ID: 15835604 [Abstract] [Full Text] [Related]
8. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN. Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031 [Abstract] [Full Text] [Related]
10. A study on the impact of FD-MDT on 200 leprosy patients. Vara N, Marfatiya Y. Indian J Lepr; 2005 Aug; 77(3):217-27. PubMed ID: 16353520 [Abstract] [Full Text] [Related]
12. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT. Shetty VP, Khambati FA, Ghate SD, Capadia GD, Pai VV, Ganapati R. Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569 [Abstract] [Full Text] [Related]
16. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M, Berhe D. Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359 [Abstract] [Full Text] [Related]
17. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Balagon MF, Cellona RV, Cruz Ed, Burgos JA, Abalos RM, Walsh GP, Saunderson PR, Walsh DS. Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628 [Abstract] [Full Text] [Related]
18. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts. Torres P, Camarena JJ, Gomez JR, Nogueira JM, Gimeno V, Navarro JC, Olmos A. Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929 [Abstract] [Full Text] [Related]
19. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study. Costa MB, Cavalcanti Neto PF, Martelli CM, Stefani MM, Maceira JP, Gomes MK, Schettini AP, Rebello PF, Pignataro PE, Ueda ES, Narahashi K, Scollard DM. Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761 [Abstract] [Full Text] [Related]
20. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy. Tejasvi T, Khaitan BK, Khanna N, Pandhi RK, Singh MK. Indian J Lepr; 2006 Sep; 78(4):329-37. PubMed ID: 17402345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]